p-Medicine: From data sharing and integration via VPH models to personalized medicine

ecancermedicalscience

Volumn 5, Issue 1, 2011, Pages

  Rossi, S ^a   Christ Neumann, M L ^b   Ruping S ^b   Buffa, F M ^c   Wegener, D ^b   McVie, G ^d   Coveney, P V ^e   Graf, N ^f   Delorenzi, M ^a  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b FRAUNHOFER IAIS   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Ecancermedicalscience   (Switzerland)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; HUMAN; PERSONALIZED MEDICINE;

EID: 84857020029     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2011.218     Document Type: Conference Paper

References (20)

1. Tursz T, Andre F, Lazar V, Lacroix L, Soria JC (2011) Implications of personalized medicine-perspective from a cancer center. Nat Rev Clin Oncol 8 177-83 PMID: 21364691 DOI: 10.1038/nrclinonc.2010.222
2. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20 589-99 PMID: 20439436 DOI: 10.1101/gr.098046.109
3. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70 2789-98 PMID: 20332227 DOI: 10.1158/0008-5472.CAN-09-3541
4. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 2817-26 PMID: 15591335 DOI: 10.1056/NEJMoa041588
5. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 530-536. (Pubitemid 34130608)
6. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15 68-74 PMID: 19122658 DOI: 10.1038/nm.1908
7. Wistuba II, Gelovani JG, Jacoby JJ, Davis SE, Herbst RS (2011) Methodological and practical challenges for personalized cancer therapies. Nat Rev Clin Oncol 8 135-41 PMID: 21364686 DOI: 10.1038/nrclinonc.2011.2
8. Hood L, Friend SH (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8 184-7 PMID: 21364692 DOI: 10.1038/nrclinonc.2010.227
9. Weston AD, Hood L (2004) Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3 179-96 PMID: 15113093
10. Auffray C, Charron D, Hood L (2010) Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med 2 57 PMID: 20804580 DOI: 10.1186/gm178
11. Gorini A, Pravettoni G (2011) P5 medicine: a plus for a personalized approach to oncology. Nat Rev Clin Oncol 8 444 PMID: 21629214
12. Gavaghan D, Coveney PV, Kohl P (2009) The virtual physiological human: tools and applications I Phil Trans R Soc A 367 1817-21 PMID: 19380313
13. Coveney PV, Diaz V, Hunter P, Kohl P and Viceconti M (2011) The Virtual Physiological Human. Interface Focus 1 281-285.
14. Mendelsohn J 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, Opening Keynote Lecture
15. Schilsk RL 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, synthesis and perspectives
16. Burgess M 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, Dawn of the personalized healthcare era: a significant step forward in patient care
17. Friend S 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, How do we study network perturbation in clinical specimens? How do we select "drivers" of malignancies?
18. Kurzrock R 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, Academic perspective: Increasing the predictive value of early phase clinical trials to screen new agents or combinations likely to be efficacious in a defined patient population
19. Pennington S 3rd WIN SYMPOSIUM in personalized cancer medicine, a significant step forward in patient care 6-8 July 2011, Paris, France, personalized proteomics for cancer - unrealistic promises or true potential?
20. Macconaill LE, Garraway LA (2010) Clinical implications of the cancer genome. J Clin Oncol 28 5219-28 PMID: 20975063 DOI: 10.1200/JCO.2009.27.4944